ArticleBMC primary care2026
Implementing screening programmes in primary care versus a centralised administration: a qualitative study of atrial fibrillation screening.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundGeneral practices have been tasked with increasing detection of atrial fibrillation (AF) to reduce stroke. Paroxysmal AF is often missed through usual care but can be detected through screening with repeated ECGs over a period of time using hand-held ECG devices. As part of the drive to detect AF, screening with such devices is being encouraged by both policy makers and industry. It is unclear whether general practice should be leading this effort. Previously, we showed that there was no quantitative difference between a centralised administration and general practice-delivered AF screening programme in terms of the quality and numbers of ECGs generated. Here, we aimed to assess the strengths and weaknesses of each approach using qualitative methods.
methodsWe compared programme delivery by one UK general practice and by a non-clinical centralised administration for two UK general practices in a qualitative study to explore how to conduct screening for AF in a planned trial. From September to December 2020, we conducted semi-structured interviews with 19 staff members. We took field notes of implementation issues arising during observation of 4.5 h of training and collected 15 training evaluation forms. Data were analysed thematically sensitised by the Consolidated Framework for Implementation Research. Analysis focused on the strengths and weaknesses of the different approaches.
resultsWhile both general practice staff and centralised administrators showed motivation to deliver a screening programme, there were differences in skills and capacity. General practice staff provided continuity of care and offer other care in parallel. They could use relational and communication skills to potentially engage those from underserved communities, but were limited by resources. Centralised administrators, with a singular focus on screening, could deliver a consistently high performance and undertake more complicated administration. Their initial anxieties about communication skills reduce with training and experience.
conclusionsIn screening for AF, primary care and centralised administration demonstrate different strengths and weaknesses. A hybrid approach with centralised screening and primary care signposting, particularly for underserved communities, might be optimal. Awareness of this may help policy makers optimise the use of primary care in the drive to detect AF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.